THC Tenet Healthcare
- 137.335
- -0.675-0.49%
Tenet Healthcare News
Is Tenet Healthcare Corporation (NYSE:THC) Expensive For A Reason? A Look At Its Intrinsic Value
Alphabet, Dropbox And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 250 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.When insiders sell shares, it could be a preplanned sale, or could indic
Insider Sale: Director Richard Fisher Sells Shares of Tenet Healthcare Corp (THC)
Tenet Healthcare(THC.US) Director Sells US$185.14K in Common Stock
$Tenet Healthcare(THC.US)$ Director FISHER RICHARD W sold 1,400 shares of common stock on Jun 10, 2024 at an average price of $132.24 for a total value of $185.14K.Source: Announcement What is stateme
Research Alert: CFRA Maintains Hold Opinion On Shares Of Tenet Healthcare Corporation
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target $36 to $154,
Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 185.14K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 10, $Tenet Healthcare(THC.US)$ Director FISHER RICHARD W intends to sell 1,400 shares of its common stock on Jun 10, with a total market value of approximately $185.14K.
Why Tenet Healthcare (THC) Is a Top Momentum Stock for the Long-Term
Zacks Investment Ideas Feature Highlights: PepsiCo, NVIDIA, Tesla and Tenet
Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $156
Goldman Sachs analyst Jamie Perse maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $85 to $156.According to TipRanks data, the analyst has a success rate of 53
How Is The Market Feeling About Tenet Healthcare?
Tenet Healthcare's (NYSE:THC) short percent of float has risen 25.1% since its last report. The company recently reported that it has 4.67 million shares sold short, which is 6.23% of all regular shar
Tenet Healthcare Lead Independent Director Joseph Kerrey Sells 51% Of Holding
Some Tenet Healthcare Corporation (NYSE:THC) shareholders may be a little concerned to see that the Lead Independent Director, Joseph Kerrey, recently sold a substantial US$3.2m worth of stock at a pr
Tenet Healthcare (THC) Is Up 3.12% in One Week: What You Should Know
Tenet Healthcare and Skyworks Solutions Have Been Highlighted as Zacks Bull and Bear of the Day
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
Tenet Healthcare Insider Sold Shares Worth $1,453,528, According to a Recent SEC Filing
Christopher S. Lynch, Director, on May 30, 2024, sold 10,861 shares in Tenet Healthcare (THC) for $1,453,528. Following the Form 4 filing with the SEC, Lynch has control over a total of 14,759 shares
Tenet Healthcare(THC.US) Director Sells US$3.19 Million in Common Stock
$Tenet Healthcare(THC.US)$ Director KERREY J ROBERT sold 23,822 shares of common stock on May 30, 31, 2024 at an average price of $133.77 for a total value of $3.19 million.Source: Announcement What i
Tenet Healthcare(THC.US) Director Sells US$1.45 Million in Common Stock
$Tenet Healthcare(THC.US)$ Director Lynch Christopher S. sold 10,861 shares of common stock on May 30, 2024 at an average price of $133.83 for a total value of $1.45 million.Source: Announcement What
Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 1.27 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 31, $Tenet Healthcare(THC.US)$ Director KERREY J ROBERT intends to sell 9,500 shares of its common stock on May 31, with a total market value of approximately $1.27 million
Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 1.92 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Tenet Healthcare(THC.US)$ Director KERREY J ROBERT intends to sell 14,322 shares of its common stock on May 30, with a total market value of approximately $1.92 millio
Tenet Healthcare Price Target Raised to $140.00/Share From $107.00 by JP Morgan
Tenet Healthcare Price Target Raised to $140.00/Share From $107.00 by JP Morgan
Analysis
Price Target
No Data
